BERLIN, GERMANY: Rachel Webster, D.Phil., M.Sc., Senior Director, Oncology, will be speaking at 2018's Combined CAR-T Congress Europe, January 30-31, 2018, on commercial opportunities for CAR-T cell therapies in Oncology.
Learn more about CAR-T cell therapies in a recent DRG Executive Briefing, CAR T-Cell Therapy: The Drive to Market.
Contact us if you’d like to set up time to meet and learn more about our Oncology solutions.
Our event speaker:
Commercial opportunities for CAR T-cell therapies in Oncology
January 31st at 17:10
Rachel Webster, D.Phil., M.Sc., Senior Director, Oncology